Skip to main content

Medicine Matters rheumatology

  • To understand how small-molecule treatments for rheumatoid arthritis differ from biologic therapies.
  • To understand the relative magnitude of efficacy of JAK inhibitors compared with biologic agents.
  • To understand the key safety issues associated with JAK inhibitors in rheumatoid arthritis.